These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 28809432)

  • 1. Intranasal administration of brain-targeted HP-β-CD/chitosan nanoparticles for delivery of scutellarin, a compound with protective effect in cerebral ischaemia.
    Liu S; Ho PC
    J Pharm Pharmacol; 2017 Nov; 69(11):1495-1501. PubMed ID: 28809432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathy.
    Wang J; Tan J; Luo J; Huang P; Zhou W; Chen L; Long L; Zhang LM; Zhu B; Yang L; Deng DY
    J Nanobiotechnology; 2017 Mar; 15(1):18. PubMed ID: 28249594
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Zhang L; Yang S; Wong LR; Xie H; Ho PC
    Mol Pharm; 2020 Nov; 17(11):4256-4269. PubMed ID: 33084343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles.
    Di Gioia S; Trapani A; Mandracchia D; De Giglio E; Cometa S; Mangini V; Arnesano F; Belgiovine G; Castellani S; Pace L; Lavecchia MA; Trapani G; Conese M; Puglisi G; Cassano T
    Eur J Pharm Biopharm; 2015 Aug; 94():180-93. PubMed ID: 26032293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of brain-targeted trendence of scutellarin nasal administration].
    Shi S; Wu J; Dai W; Li C; Ge W
    Zhongguo Zhong Yao Za Zhi; 2010 Sep; 35(18):2453-6. PubMed ID: 21141499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification and Brain Targeting of Eugenol-Loaded Surface Modified Nanoparticles Through Intranasal Route in the Treatment of Cerebral Ischemia.
    Ahmad N; Ahmad R; Alam MA; Ahmad FJ
    Drug Res (Stuttg); 2018 Oct; 68(10):584-595. PubMed ID: 29669380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained release and enhanced bioavailability of injectable scutellarin-loaded bovine serum albumin nanoparticles.
    Wei Y; Li L; Xi Y; Qian S; Gao Y; Zhang J
    Int J Pharm; 2014 Dec; 476(1-2):142-8. PubMed ID: 25269007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
    Saini D; Fazil M; Ali MM; Baboota S; Ali J
    Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.
    Wang X; Chi N; Tang X
    Eur J Pharm Biopharm; 2008 Nov; 70(3):735-40. PubMed ID: 18684400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclodextrin pendant polymer as an efficient drug carrier for scutellarin.
    Liao R; Liu Y; Lv P; Wu D; Xu M; Zheng X
    Drug Deliv; 2020 Nov; 27(1):1741-1749. PubMed ID: 33307844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
    Rukmangathen R; Yallamalli IM; Yalavarthi PR
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
    [No Abstract]   [Full Text] [Related]  

  • 12. Intranasal chitosan-g-HPβCD nanoparticles of efavirenz for the CNS targeting.
    Belgamwar A; Khan S; Yeole P
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):374-386. PubMed ID: 28423949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer's disease in intracerebroventricular streptozotocin model for brain delivery.
    Zameer S; Ali J; Vohora D; Najmi AK; Akhtar M
    J Drug Target; 2021 Feb; 29(2):199-216. PubMed ID: 32876502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
    Md S; Khan RA; Mustafa G; Chuttani K; Baboota S; Sahni JK; Ali J
    Eur J Pharm Sci; 2013 Feb; 48(3):393-405. PubMed ID: 23266466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesalazine/hydroxypropyl-β-cyclodextrin/chitosan nanoparticles with sustained release and enhanced anti-inflammation activity.
    Tang P; Sun Q; Zhao L; Pu H; Yang H; Zhang S; Gan R; Gan N; Li H
    Carbohydr Polym; 2018 Oct; 198():418-425. PubMed ID: 30093018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC/mass spectrometry method.
    Md S; Haque S; Fazil M; Kumar M; Baboota S; Sahni JK; Ali J
    Expert Opin Drug Deliv; 2014 Jun; 11(6):827-42. PubMed ID: 24655115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of Cerebral Ischemia.
    Ahmad N; Ahmad R; Naqvi AA; Alam MA; Ashafaq M; Samim M; Iqbal Z; Ahmad FJ
    Int J Biol Macromol; 2016 Oct; 91():640-55. PubMed ID: 27264648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
    Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
    Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain targeted nanoparticulate drug delivery system of rasagiline via intranasal route.
    Mittal D; Md S; Hasan Q; Fazil M; Ali A; Baboota S; Ali J
    Drug Deliv; 2016; 23(1):130-9. PubMed ID: 24786489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
    Fazil M; Md S; Haque S; Kumar M; Baboota S; Sahni JK; Ali J
    Eur J Pharm Sci; 2012 Aug; 47(1):6-15. PubMed ID: 22561106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.